type here...

Clayton Act

Antitrust as a Cure for the Private Equity Disease

Theodosia Stavroulaki
The United States healthcare system has experienced an expansion of private equity ownership. In new research, Theodosia Stavroulaki argues that private equity acquisitions risk harming healthcare by increasing prices, reducing quality of care, limiting access to care, and hurting the labor force.

The Clayton Act Does Not Allow an Efficiency Defense

Robert H. Lande
Robert H. Lande and Mark Glick respond to recent articles by Nancy Rose & Jonathan Sallet and Herbert Hovenkamp debating the role of an...

LATEST NEWS

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.